The Design and Development of Improved Fluorocarbon-Based Products for use in Medicine and Biology

References

• Riess J. G. Overview of Progress in the Fluorocarbon Approach to in vivo Oxygen Delivery. Blood Substitutes and Oxygen Carriers, TMS. Chang. M. Dekker, New York 1993; 24–43
   Google Scholar
• Riess J. G. Fluorocarbon-Based in vivo Oxygen Transport and Delivery Systems. Vox Sang. 1991; 61: 225–239
   PubMed Web of Science ®Google Scholar
• Faithfull N. S. Artificial Oxygen Carrying Blood Substitutes. Oxygen Transport to Tissues XIV, W. Erdmann, D.F. Bruley. Plenum Press, New York 1992; 317: 55–72, 1992 Adv. Exp. Med. Biol.
   Google Scholar
• Riess J. G. Chap 14., Hemocompatible Fluorocarbon Emulsions. Blood Compatible Materials and Devices, Szycher Sharma. Technomics Publ. Co, Lancaster, Pa, USA 1991; 237–270
   Google Scholar
• Riess J. G., Le Blanc M. Solubility and Transport Phenomena in Perfluorochemicals Relevant to Blood Substitution and Other Biomedical Applications. Pure & Appl. Chem. 1982; 54: 2383–2406
   Web of Science ®Google Scholar
• Riess J. G., Le Blanc M. Chap. 5., Preparation of Perfluorochemical Emulsions for Biomedical Use: Principles, Materials and Methods. Blood Subtitutes: Preparation, Physiology and Medical Applications, K.C. Lowe. Ellis Horwood Ltd, Chichester 1988; 94–129
   Google Scholar
• Mercuriali F., Inghilleri G., Biffi E., Vinci A., Colotti M. T. The Potential Role of Oxygen-Carrying Products in Autologous Blood. Transfusion Protocols These Proceedings
   Google Scholar
• Zuck T. F., Carey P. M. Autologous Transfusion Practice. Vox Sang. 1990; 58: 234–253
   PubMed Web of Science ®Google Scholar
• Zuck T. F. Difficulties in Demonstrating Efficacy of Blood Substitutes These Proceedings
   Google Scholar
• Mattrey R. F. Perfluorooctyl bromide: A New Contrast Agent for CT, Sonography and MR imaging. AJR. 1989; 152: 247–252
   PubMed Web of Science ®Google Scholar
• Mattrey M. A., Trambert J. J., Brown J. N., Bruneton S. W., Young R. F., Schooley G. L. Results of the Phase III Trials with Imagent GI as an Oral Magnetic Resonance Contrast Agent. Invest. Radiol. 1991; 26: S65–S66
   PubMedGoogle Scholar
• Rubin D. L., Muller H. H., Nino-Murcia M., Sidhu M., Christy V., Young S. W. Intraluminal Contrast Enhancement and MR Visualization of the Bowel Wall: Efficacy of PFOB. JMRI 1991; 1: 371–380
   Web of Science ®Google Scholar
• Eilenberg V. M., Tartar S. S., Mattrey R. F. Reducing Magnetic Susceptibility Differences Using Liquid Fluorocarbon Pads (SAT PAD(tm)): Results with Spectral Presaturation of Fat. These Proceedings.
   Google Scholar
• Wolf G., Long D., Riess J. G. Percutaneous Lymphography with PFOB. Radiology 1990; 177: 366
   Google Scholar
• Hanna G., Saewert D., Shorr J., Flaim K., Leese P., Kopperman M., Wolf G. Preclinical and Clinical Studies on Lymph Node Imaging Using Perflubron Emulsion. These Proceedings.
   Google Scholar
• Bruneton M. N., Francois E., Cambon P., Falewee C., Philip J. G., Riess J. N., Balumaestro C., Rogopoulos A. Liver, Spleen and Vessels: Preliminary Clinical Results of CT with Perfluorooctylbromide. Radiology 1989; 170: 179–184
   PubMed Web of Science ®Google Scholar
• Behan M., O'Connell D., Mattrey R. F., Carney D. N. Perfluorooctylbromide as a Contrast Agent for CT and Sonography: Preliminary Clinical Results. AJR 1993; 160: 399–405
   PubMed Web of Science ®Google Scholar
• Fuhrman P. R., Paczan B. P., De Francisis M. Perfluorocarbon Associated Gas Exchange. Crit. Care Med. 1991; 19: 712–723
   PubMed Web of Science ®Google Scholar
• Fuhrman B. P., Hernan L. J., Holm B. A., Leach C. L., Papo M. C., Steinhorn D. M. Perfluorocarbon Associated Gas Exchange (PAGE): Gas Ventilation of the Perfluorocarbon Filled Lung. These Proceedings
   Google Scholar
• Lachmann B., Tütüncü A. S., Bos J.A.H., Faithfull N. S., Erdmann W. Perflubron (Perfluorooctylbromide) Instillation Combined with Mechanical Ventilation: An Alternative Treatment of Acute Respiratory Failure in Adult Animals. Oxygen Transport to Tissue XIV, W. Erdmann, D.F. Bruley. Plenum Press, New York 1992
   Google Scholar
• Wolfson M. R., Shaffer T. H. Liquid Ventilation during Early Development: Theory, Physiology Process and Application. J. Develop. Physiol. 1990; 13: 1–12
   PubMedGoogle Scholar
• Shaffer T. H., Wolfson M. R., Greenspan J. S., Rubenstein S. D., Stern R. G. Perfluorochemical Liquid as a Respiratory Medium. These Proceedings
   Google Scholar
• Jackson J. C., Standaert T. A., Truog W. E., Hodson W. A. Full-Tidal Liquid Ventilation with Perfluorocarbon for Prevention of Lung Injury in Newborn Non-Human Primates. These Proceedings.
   Google Scholar
• Wolfson J. S., Greenspan M. R., Shaffer T. H. Pulmonary Administration of Vasoactive Drugs (PAD) by Perfluorocarbon Liquid Ventilation. Meeting Soc. Pediatr. Res. 1992
   Google Scholar
• Long C. B., Higgins R. F., Mattrey R. M., Mitten D. M., Multer F. K. Is there a Time and Place for Radiopaque Fluorocarbons?. Preparation, Properties, and Industrial Applications of Organofluorine Compounds, R.E. Banks. Ellis Horwook Publishers. 1982; 139–156
   Google Scholar
• Wolfson M. R., Stern R. G., Kechner N., Sekins K. M., Shaffer T. H. Utility of a Perfluorochemical Liquid for Pulmonary Diagnostic Imaging. These Proceedings.
   Google Scholar
• Naito R., Yokoyama K. Perfluorochemical Blood Substitutes. FC-43 Emulsion Fluosol-DA, 20% and 35%. Technical Information 1990, Ser. N 5 and 7 (The Green Cross Corp., Osaka, 1978, 1981); Fluosol, Product Monograph, Alpha Therapeutic Corp.
   Google Scholar
• Beloyartsev E. I., Mayevsky F. F., Islamov B. I. Ftorosan-Oxygen-Carrying Perfluorochemical Plasma Substitute. Acad. Sci. USSR, Pushchino 1983
   Google Scholar
• Obrazstov V. Fluorocarbon Blood Substitutes in Russia. These Proceedings.
   Google Scholar
• Chen Z. H., Yang H. S., . Perfluorocarbon as Blood Substitute in Clinical Applications and in War Casualties. Blood Substitutes, T.M.S. Chang, R.P. Geyer, et al. M. Dekker, New York 1989; 403–410
   Google Scholar
• Riess J. G. Reassessment of Criteria for the Selection of Perfluorochemicals for Second-Generation Blood Substitutes: Analysis of Structure/Property Relationships. Artif. Org. 1984; 8: 44–56
   PubMed Web of Science ®Google Scholar
• Kaufman T. H., Goodin R., Richard T. J. Efficacy of Perfluorochemical Emulsions in Surgical Anemia and Shock Resuscitation. These Proceedings.
   Google Scholar
• Riess J. G. Blood Substitutes: Where Do We Stand with the Fluorocarbon Approach?. Current Surg. 1988; 45: 365–370
   PubMedGoogle Scholar
• Riess J. G. Post-Fluosol Progress in Fluorocarbon Emulsions for in vivo Delivery. Trasfus. Sang. 1987; 32: 316–334
   Google Scholar
• Weers J. G., Liu B. A., Arlauskas J., Resch P., Fields T., Cavin J. Room Temperature Stable Fluorocarbon Emulsions with Acceptable Half-Lives in the Reticuloendothelial System. These Proceedings.
   Google Scholar
• Riess J. G. Highly Fluorinated Compounds for Use in Medicine and Biology. Colloids and Surfaces, in press
   Google Scholar
• Riess J. G., Santaella C., Vierling P. New Perfluoroalkylated Phosphatidylcholines as Surfactants for Biomedical Applications. Proceed. XXIIe CED Meeting on Surfactants, Palma de Mallorca, Comite Espagnol Detergencia, Tensioactivos, Y. Afines. Barcelona, Spain 1991; 157–171
   Google Scholar
• Santaella C., Vierling P., Riess J. G. Highly Stable Liposomes Derived from Perfluoroalkylated Glycerophosphocholines. Angew. Chem. Intl. Ed. 1991; 30: 567–568
   Web of Science ®Google Scholar
• Sanchez V., Zarif L., Greiner J. G., Riess J., Cippolini S., Bruneton J. N. Novel Injectable Fluorinated Contrast Agents with Enhanced Radiopacity. These Proceedings.
   Google Scholar
• Hammerschmidt D. E., Vercelloti G. M. Limitation of Complement Activation by Perfluorocarbon Emulsions: Superiority of Lecithin-Emulsified Preparations. Blood Substitutes, T.M.S. Chang, R.P. Geyer. M. Dekker, New York 1989; 431–438
   Google Scholar
• Riess J. G., Postel M. Stability and Stabilization of Fluorocarbon Emulsions Destined for Injection. Biomat., Art. Cells & Immob. Biotech. 1992; 20: 819–830
   PubMed Web of Science ®Google Scholar
• Postel M., Riess J. G., Weers J. Fluorocarbon Emulsions: The Stability Issue. These Proceedings.
   Google Scholar
• Long D. C., Long R. F., Mattrey R. A., Long A. R., Burgan W. C., Herrick D. M., Shellhamer D. F. An Overview of Perfluoroctylbromide-Application as a Synthetic Oxygen Carrier and Imaging Agent for X-Ray, Ultrasound and Nuclear Magnetic Resonance. Blood Substitutes, T.M.S. Chang, R.P. Geyer. M. Dekker, New York 1989; 411–420
   Google Scholar
• Long D. C., Long D. M., Riess J. G., Follana R., Burgan A., Mattrey R. F. Preparation and Application of Highly Concentrated Perfluorooctylbromide Fluorocarbon Emulsions. Blood Substitutes, T.M.S. Chang, R.P. Geyer. M. Dekker, New York 1989; 441–442
   Google Scholar
• Riess J. L., Dalfors G. K., Hanna D. H., Klein M. P., Krafft T. J., Pelura J. G., Schutt E. G. Development of Highly Fluid, Concentrated and Stable Fluorocarbon Emulsions for Diagnosis and Therapy. Biomat., Art. Cells and Immob. Biotech. 1992; 20: 839–842
   PubMed Web of Science ®Google Scholar
• Faithfull N. S. Oxygen Delivery from Fluorocarbon Emulsions-Aspects of Convective and Diffusive Transport. Blood Substitutes and Oxygen Carriers, T.M.S. Chang. M. Dekker, New York 1993; 569–576
   Google Scholar
• Flaim D. R., Hazard S. F., Hogan J., Peters R. M. Characterization and Mechanism of Side-Effects of Imagent BP (Highly Concentrated Fluorocarbon Emulsion) in Swine. Invest. Radiol. 1991; 26: S122–S124
   Web of Science ®Google Scholar
• Flaim S. Pharmacokinectics and Side Effects of Perfluorocarbon-Based Blood Substitutes. These Proceedings.
   Google Scholar
• Lustig R., McIntosh-Lowe N., Rose C., Haas J., Krasnow S., Spaulding M., Prosnitz L. Phase I/II Study of Fluosol-DA and 100% Oxygen as an Adjuvant to Radiation in the Treatment of Advanced Squamous Cell Tumors of the Head and Neck. Int. J. Radiol. Oncol. Biol. Phys. 1989; 16: 1587–1593
   PubMed Web of Science ®Google Scholar
• Evans R. G., Kimler B. F., Moranz R. A., Vats T. S., Gemer L. S., Liston V., Lowe N. Phase I/II Study of the Use of Fluosol-DA 20% an Adjuvant to Radiation in the Treatment of Primary High-Grade Brain Tumors. Int. J. Radiol. Oncol. Biol. Phys. 1990; 19: 415–420
   PubMed Web of Science ®Google Scholar
• Clark R. E., Hoffmann L. C., Davis S. L. Response of the Rabbit Lung as a Criterion of Safety for Fluorocarbon Breathing and Blood Substitutes. Biomat., Art. Cells and Immob. Biotech. 1992; 20: 1085–1099
   PubMed Web of Science ®Google Scholar
• Goodin T. H., Kaufman R. J., Richard T. J. Comparative Pulmonary Toxicity of three Perfluorochemicals in the Rat and Baboon. These Proceedings.
   Google Scholar
• Schutt E., Barber P., Fields T., Flaim S., Horodniak P. E., Keipert J., Kinner R., Kornburst L., Leakakos T., Pelura T., Weers J., Houmes R., Lachmann B. Proposed Mechanism of Pulmonary Gas Trapping (PGT) Following Intra-Venous Perfluorocarbon Emulsion Administration. These Proceedings.
   Google Scholar
• Davis K. C., Lowe S. S., Sharma S. K. Novel Compositions of Emulsified Perfluorocarbons for Biological Applications. Br. J. Pharmac 1986; 89: 665P
   Google Scholar
• Moghimi S. M., Porter C. J.H., Muir I. S., Illum L., Davis S. S. Biochem. Biophys. Res. Commun. 1991; 177: 861–866
   PubMed Web of Science ®Google Scholar
• Woodle M. C., Lasic D. D. Sterically Stabilized Liposomes. Biochimica et Biophysica Acta 1992; 1113: 171–199
   PubMed Web of Science ®Google Scholar
• Blume G., Cevc G. Drug-Carrier and Stability Properties of the Long-Lived Lipid Vesicles, Cryptosomes, in Vitro and in Vivo. J. Liposome Res. 1992; 2: 355–368
   Google Scholar
• Park Y. S., Maruyama K., Huang L. Some Negatively Charged Phospholipid Derivatives Prolong the Liposome Circulation in Vivo. Biochimica et Biophysica Acta 1992; 1108: 257–260
   PubMed Web of Science ®Google Scholar